Introduction: Yuankang has now formed an investment pattern with the Yangtze River Delta as the center and radiating the whole country. In the future, we will gradually build a strategic commanding height based on Shanghai, Beijing and other first-tier central cities, look at the whole country, go to Asia and connect with the world, and strive to develop into an influential national high-tech biotechnology enterprise at home and abroad. In the future, Yuankang will also establish the largest tumor biotherapy network system in China by integrating the technical data of various hospitals. We will develop together with cooperative hospitals in the improvement of biotherapy rules, the publicity of biotherapy knowledge, the training of biotherapy doctors and researchers, the enjoyment of case resources and the enjoyment of technical resources. Shanghai Yuankang Biotechnology Co., Ltd. (hereinafter referred to as Yuankang) is a company specializing in medical investment and management. It is a professional medical investment company that mainly develops, invests and operates public 3A hospitals, and makes joint-stock investment in medical services through acquisition, entrusted management, merger and self-construction. Yuankang is a national high-tech enterprise focusing on basic research, clinical application research and industrialization promotion of biotherapy. The company specializes in tumor immunotherapy and clinical research, and is currently the most professional tumor medical institution in China. Based on technology research and development, and relying on Bai Rui International Cancer Treatment Center of Shanghai Ruijin Hospital, Yuankang has attracted a large number of domestic and foreign experts and established a perfect scientific research platform through talent introduction and cooperation and exchange. The company established Yuankang Institute of Biological Drugs and Products in conjunction with hospitals, scientific research institutes and enterprises to carry out applied research on biological treatment of diseases. At present, the overall curative effect of autoimmune cells in tumor treatment is remarkable. Corporate vision has become the most professional cancer medical institution in China, with its own brand of 3A cancer hospital, which has been successfully listed. Corporate mission promotes the development of national cancer cause. The purpose of the enterprise is to make life a "tumor" because of our existence. The concept of talent is people-oriented, and elitism is a corporate value that operates in a highly flexible market and is highly vigilant against risks. Life and health are the greatest values of an enterprise. The requirements for employees are first: sense of ownership, second: diligence and innovation, fourth: loyalty and gratitude, and team spirit.
Legal Representative: Zhang Peng.
Date of establishment: September 2, 20071
Registered capital: 500,000 yuan.
Industrial and commercial registration number: 310107000516940.
Enterprise type: limited liability company (natural person investment or holding)
Company address: No.3, Room 804, No.941Jiaozhou Road, Putuo District, Shanghai.